✨ Education and Health Notices
842 NEW ZEALAND GAZETTE, No. 32 22 MARCH 2007
Board of Trustees held on 29 March 2007, and require
a new election to be held on 25 May 2007, and declare that
the trustees holding office on 29 March 2007, remain in
office until the close of the day before the day when the
new trustees takes office.
This notice takes effect on the day of notification.
Dated at Wellington this 15th day of March 2007.
KATHY PHILLIPS, Senior Manager, National Operations.
go1800
Health
Medicines Act 1981
Consent to the Distribution of a Changed Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the changed medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set
out in the Schedule hereto:
Schedule
Product: Keppra
Active Ingredient: Levetiracetam 1,000mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Wyber Debra
Manufacturer: UCB SA, Pharmaceutical Sector, Braine-l’Alleud, Brussels, Belgium
Product: Keppra
Active Ingredient: Levetiracetam 250mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Wyber Debra
Manufacturer: UCB SA, Pharmaceutical Sector, Braine-l’Alleud, Brussels, Belgium
Product: Keppra
Active Ingredient: Levetiracetam 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Wyber Debra
Manufacturer: UCB SA, Pharmaceutical Sector, Braine-l’Alleud, Brussels, Belgium
Product: Keppra
Active Ingredient: Levetiracetam 750mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Wyber Debra
Manufacturer: UCB SA, Pharmaceutical Sector, Braine-l’Alleud, Brussels, Belgium
Dated this 15th day of March 2007.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go1848
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the new medicines set out in the Schedule hereto:
Schedule
Product: Actilax
Active Ingredient: Lactulose 66%w/v
Dosage Form: Syrup
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Lacsa Pty Limited, Merebank, Durban, South Africa
Product: Flubiclox
Active Ingredient: Flucloxacillin sodium monohydrate 500mg
Dosage Form: Powder for injection
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Istituto Biochimico Italiano Giovanni Lorenzini SpA, Aprilia (LT), Italy
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2007, No 32
Gazette.govt.nz —
NZ Gazette 2007, No 32
✨ LLM interpretation of page content
🎓 Aotea College Board of Trustees Election Invalidation Notice
🎓 Education, Culture & Science15 March 2007
Education Act, Board of Trustees, Election Invalidation, Aotea College
- KATHY PHILLIPS, Senior Manager, National Operations
🏥 Consent to the Distribution of a Changed Medicine
🏥 Health & Social Welfare15 March 2007
Medicines Act, Medicine Distribution, Keppra, Levetiracetam
- Debra Wyber, New Zealand Sponsor
- DON MATHESON, Deputy Director-General, Public Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social WelfareMedicines Act, Medicine Distribution, Actilax, Flubiclox